-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Conduit Pharmaceuticals Inc. quarterly/annual General and Administrative Expense history and growth rate from 2022 to 2024.
- Conduit Pharmaceuticals Inc. General and Administrative Expense for the quarter ending June 30, 2025 was $3.09M, a 0.74% decline year-over-year.
- Conduit Pharmaceuticals Inc. General and Administrative Expense for the twelve months ending June 30, 2025 was $11.9M, a 36.5% increase year-over-year.
- Conduit Pharmaceuticals Inc. annual General and Administrative Expense for 2024 was $12M, a 133% increase from 2023.
- Conduit Pharmaceuticals Inc. annual General and Administrative Expense for 2023 was $5.17M, a 69.6% increase from 2022.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)